Service Overview:
Biostatistics services is based on the guidelines of regulatory agencies (NMPA and FDA, etc.) and other relevant regulations, combined with the rich experience in pharmaceutical companies and CROs, to provide pharmaceutical companies with high-quality and professional innovative solutions to effectively enhance the statistical efficiency and accelerate the progress of R&D of new drugs.
Applying innovative statistical design methods, saving research cost and speeding up the trial process:
Apply Bayesian statistical methods to improve the probability of accurately finding MTDs by using experimental design methods such as BOIN, i3+3, mTPI-2, R-TPI, etc. in phase Ia dose climbing. Enhance R&D efficiency through the transparency of decisions and the flexibility and user-friendliness of flowcharts and decision tables.
In the Phase Ib dose extension trials, use simultaneous multi-dose, multi-indication expansion to save trial sample size, increase flexibility, and save development time.
Main Protocol and Seamless Design: Simultaneous study of multiple therapeutics or/multiple diseases in a single protocol; Umbrella/basket/platform design for multiple groups or co-controls and simultaneous screening of multiple biomarkers; Full utilization of data from all phases to improve statistical efficacy and shorten R&D time.
Our Services:
Clinical Development Strategy (CDP) Statistical Consulting
Trial Design and Clinical Protocol Statistical Support
Randomization protocol development and implementation
Statistical Analysis Plan (SAP) and TFL writing and implementation
Interpretation of study results and report writing
Communicating with Regulatory Agency Statistical Reviewers
IDMC/DSMB's third-party independent statistician services
Statistical consulting and training
Our Differentiations:
Internationalized business capacity
Taking the international standard CDISC as the standard data format and following the meticulous requirements and high standards of ICH-GCP, we have the ability to provide dual reporting in China and the U.S. as well as global multi-center services;
Flexible and innovative cooperation model
Biostatistics full-range service, outsourcing FSP, strategic cooperation with pharmaceutical companies, statistical support, statistical expert consulting and training, assistance in the "management" of the outsourcing statistical suppliers;
Professional Team
Biostatistics management team: with domestic and international well-known pharmaceutical companies or CRO management experience, an average of 15 + years of industry experience; Core technical team: an average of 7+ years of biostatistical experience in clinical trials of innovative drugs, with rich domestic and international project experience.
Service Overview:
Our data science services are based on CDISC international data standards, and the data management procedures are guided by FDA and NMPA mainstream data guidelines. Providing differentiated and customized services for pharmaceutical companies. UnionLab introduces the Electronic Data Capture system with international advanced technology skill: TrialMaster. In order to align with China clinical research needs, accelerate the data processing, and bring more value to our customer, UnionLab localized the system by deploying domestic servers.
Our Service:
Data Management Document, include DMP (Data Management Plan), DVP (Data Validation Plan), CCG (CRF Completion Guidance), Coding Plan and Convention, eDTA (External Data Transfer Agreement), SAE Reconciliation Plan, PDS (Protocol Deviation Specification), DRR (Data Review Report), DMR (Data Management Report), etc.
CRF/eCRF design (per CDISC.CDASH standard)
CDMS (Clinical Data Management System) and related modules establish and test
Online data clean and data status report
Offline listing program and manual review
Medical event and drug coding
External data reconciliation
SAE (Serious Adverse Event) reconciliation
PD (Protocol Deviation) management
(Blinded) Data Review Meeting management
Database lock and raw data transfer
Data management consulting and training
TrialMaster system training
Our Differentiations:
The Data Science management team own more than 10 years industry experience. The data management teams have more than 5 years industry experience and own rich international and domestic clinical trial data management experience. The database programming team has more than 7 years industry experience and familiar with international and domestic clinical data management system. Both the data management and database programming follow the national agency regulations, support both regular data processing and specific data requirement, such as interim analysis, seamless bridge the source data and analysis requirements, meet the real-time needs of clinical data.
Service Overview:
Our statistical analysis services are based on CDISC international data standards, independent double-programming quality control processes, and data submission standards guided by US FDA and China NMPA mainstream data guidelines. It provides high-quality, efficient, and professional data analysis services for pharmaceutical companies, offers rapid and accurate data analysis support for key clinical decisions, and accelerates the development of new drugs.
Our Service:
CDISC Standard Data (SDTM/ADaM)
Statistical analysis Tables, Figures, and Listings (TFLs)
Interim analysis and support for IDMC statistical analysis
NDA/BLA eCTD M5 electronic data submission for new drug market approval (including Case Report Form (CRF) annotations, SDTM, ADaM, Define files, cSDRG and ADRG, etc.)
Integrated Summary of Safety/Efficacy Analysis (ISS/ISE)
Data analysis support for other clinical services (IND, PD, CSR, SMC, MMR, DSUR, etc.)
Preclinical and clinical pharmacology data statistical analysis
IRC data management and standardization
Consulting and training on data standards
Our Differentiations:
Nearly half of our team members have more than 6 years of industry experience, boasting rich experience in statistical analysis of clinical trials both domestically and internationally. Statistical programming work follows the internationally leading CDISC data standards, with double-blind programming to ensure delivery quality and fulfill various analytical requirements stated in the statistical analysis plan. The team can smoothly meet submission requirements of various regulatory agencies (such as FDA, NMPA, etc.) and handle their mutual conversions and integrations.
Union Laiya is a corporate member of CDISC and could fully utilize the resources and support provided by CDISC to its corporate members for the benefit of our clients.
Service Overview:
TrialMaster is global leading EDC system developed by American Anju company, which combines various modules include both the basic modules such as Coding, IRT, ePRO, etc., and the advanced modules such as Translation, SafetyLink, Acuity Analytics, etc. The main architect is from Medidata, and the system frame is on the same page with Medidata RAVE. More than 400 projects and 20 products was approved by FDA on TrialMaster. After expanding to China market since 2018, already has product approved by NMPA as well. UninonLab obtained TrialMaster official authorization at 2020, localized the system by deploying domestic servers and obtaining the real-time data for dynamic decision from mobile end.
Our Service:
TrialMaster EDC
TrialBuilder
TrialExplorer
Auto-Encoder
Local Lab Range
IRTMaster
eLearning
Translation
File import
Data export
SafetyLink
OmniConnectAPIs
AnjuDV
Our Differentiations:
TrialMaster specific system functions:
Easy to access and use
Adopting Liquid Layout adaptive interface design, the system can automatically adjust the screen display size when users use different devices, making it very convenient for users to use on screens of different sizes.
Real time feedback on query
Users receive real-time guidance feedback when entering data, thereby minimizing data input errors and expensive data cleaning costs.
Multi language support
TrialMaster can be translated into any number of other languages and stored in a global translation database. Users can choose the system language they want to use.
UnionLab localized EDC system characters:
Localized deployment, localized technical support
The system server is operated and maintained by the UnionLab Intelligent Development Team in China.
More in line with the practical needs of clinical research in China
While following the upgrade of the original system version, the development team of UnionLab Intelligence is responsible for updating the detailed functions.
Technical functions are consistent with international frontline EDC systems, and FDA compliance requirements:
Complete audit trial, automatically recorded by the system, accurate to seconds
Independent laboratory module, independent medical coding module, powerful data reporting function (customized reports)
When the site personnel enter lab data value, TrialMaster will automatically fill in the matched local lab normal range and units on the eCRF page, automatically judge the test results as "low/high/normal” and provide clinical significance for outliers immediately. Related medical terms will be automatically encoded, and if no matching terms are found, they will be marked as manually encoded. A concise and user-friendly coding interface helps authorized personnel to carry out coding work quickly and efficiently. Real time data insights and analysis graphs can help reduce regulatory risks and improve data quality and compliance.
Accurate authority management
Through central user management and single sign on functionality, users only need a single username/password to access all of their research and perform personal ID authentication.
Service Overview:
In addition to providing traditional biostatistics, data management, statistical analysis and programming services, UnionLab Laiya also offers numerous innovative services related to quantitative science, clinical trial data, and new technologies, aimed at better serving the scientific and efficient planning, design, implementation, and submission of clinical trials.
Our Service:
Clinical development plans for multiple therapeutical areas with our seasoned partners and experts
Innovative study designs and development with our professor-level experts and partners
CDISC standard implementation strategy and consulting
Risk-based monitoring (RbM) consulting and implementation
Innovative data visualization tool development
Decentralized clinical trial (DCT) implementation consulting (co-development with partners and experts)
R language implementation and training (co-development with partners and experts)
Our Differentiations:
Our own experienced professional and experts
Partnership with multiple academic and industry experts